Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026

HLF vs BHST: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

HLF Wins Head-to-Head Institutional Verdict (5–1 across 6 Pillars · 9–1 Matrix Metrics)

HLF Overall Winner 6-Pillar Tally: HLF 5 – 1 BHST Matrix Metrics: HLF 9 – 1 BHST

As of Nov 20, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HLF carries a Unified Composite Score of 47.4/100 (HOLD) at $15.53 (5.1x Forward P/E, 9.8% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin).

  • Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. HLF 47.4/100 HOLD), HLF captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -18.0% operating margin) and revenue trajectory (+6.0% vs. +3.8% YoY).
  • Technical & Structure Timing Caution: HLF trades in a Markup technical trend (SURGE options phase, RSI 59.0); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About HLF vs BHST
HLF NYSE Head-to-Head Winner
Herbalife Ltd.
Wholesale-Drugs, Proprietaries & Druggists' Sundries
$15.53
-0.26% 1D
Market Cap $1.6B
TTM Revenue $5.28B
Forward P/E 5.1x
Beta / 30D Vol 1.02β · 50% Vol
Unified Composite Score
47.4 / 100 HOLD
Tech 31.0 Fund 46.0 Flow 60.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (8.1% over 20 days), RSI 59
RSI-14: 59.0 · SMA20: $14.81 · SMA50: $13.63
BHST NASDAQ
BioHarvest Sciences Inc. Common Stock
Pharmaceutical Preparations
$1.30
-1.52% 1D
Market Cap $29.9M
TTM Revenue $35M
Forward P/E N/M
Beta / 30D Vol 0.25β · 86% Vol
Unified Composite Score
58.2 / 100 HOLD
Tech 75.0 Fund 57.0 Flow 50.0 Mom 60.0
Weinstein Technical Phase Markdown · Sell / avoid
Price below a falling SMA50 (slope -9.1%), weak momentum, RSI 37
RSI-14: 37.2 · SMA20: $1.55 · SMA50: $1.58

6-Pillar Scorecard Institutional Category Breakdown (HLF 5 – 1 BHST)

Columns: Metric · HLF · BHST
1. Valuation Multiples HLF
Forward P/E 5.1x N/M
Trailing P/E 9.2x N/M
PEG Ratio 0.61x N/M
EV / Revenue 0.6x 0.7x
2. Growth & Scale HLF
Revenue Growth (YoY) +6.0% +3.8%
Earnings Growth (YoY) +31.5% +0.0%
TTM Revenue (USD) $5.28B $35M
Market Cap $1.6B $29.9M
3. Profitability & Quality HLF
Gross Margin 77.6% 59.0%
Operating Margin 9.8% -18.0%
Net Profit Margin 3.4% -31.2%
Return on Equity (ROE) 0.0% -142.5%
4. Balance Sheet & Cash Flow HLF
Cash Generation (TTM) $337M -$9.4M
Cash Flow Margin 6.4% -26.6%
Net Cash / Leverage $1.70B Net Debt $5.1M Net Cash
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning HLF
Options Structure Phase SURGE UNCLASSIFIED
Current IV / %ile 47.1% (4th %ile) N/A (N/A)
Put/Call OI Skew 0.23x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markdown
6. R&D & Supply-Chain Moat BHST
OpEx & R&D Intensity 67.8% of Rev ($3.58B) 77.0% of Rev ($27M)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Packaged Foods Operator Packaged Foods Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: HLF (9) vs BHST (1)
Institutional Metric HLF BHST Criterion Row Edge
Market Capitalization
Scale
$1.6B $29.9M Larger Scale HLF
Trailing P/E Ratio
Valuation
9.2x N/M Lower Multiple HLF
Forward P/E Ratio
Valuation
5.1x N/M Lower Multiple HLF
Revenue Growth (YoY)
Growth
+6.0% +3.8% Higher Growth HLF
Operating Margin (TTM)
Profitability
9.8% -18.0% Higher Margin HLF
Net Profit Margin
Profitability
3.4% -31.2% Higher Margin HLF
Return on Equity (ROE)
Capital Efficiency
0.0% -142.5% Higher ROE HLF
52-Week Range Position
Momentum
58% ($9–$20) 6% ($1–$7) Stronger Trend HLF
Beta / 30D Volatility
Risk Regime
1.02β · 50% Vol 0.25β · 86% Vol Lower Realized Risk HLF
Unified Institutional Score
Composite Signal
47.4 / 100 (HOLD) 58.2 / 100 (HOLD) Higher Composite BHST
Trailing 12M Revenue (USD)
Operating Scale
$5.28B $35M FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
77.6% 59.0% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
0.61x PEG · 0.6x EV/Rev N/M PEG · 0.7x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$337M ($1.70B Net Debt) -$9.4M ($5.1M Net Cash) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon HLF +35.32 pp
HLF: +12.7% · BHST: -22.62%
3M Horizon HLF +60.04 pp
HLF: +23.45% · BHST: -36.59%
6M Horizon HLF +91.26 pp
HLF: +24.94% · BHST: -66.32%
1Y Horizon HLF +147.84 pp
HLF: +68.44% · BHST: -79.4%

Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)

Split-Invariant USD Revenue & Operating Margin (%)
Period HLF Revenue BHST Revenue HLF Op. Margin BHST Op. Margin Margin Leader
FY2018 $4.89B N/A 14.0% N/A HLF
FY2019 $4.88B N/A 11.6% N/A HLF
FY2020 $5.54B N/A 11.6% N/A HLF
FY2021 $5.80B N/A 12.7% N/A HLF
FY2022 $5.20B N/A 10.5% N/A HLF
FY2023 $5.06B $10M 7.0% -78.6% HLF
FY2024 $4.99B $30M 7.7% -27.7% HLF
FY2025 $5.04B $30M 9.5% -16.2% HLF

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
HLF SURGE
5d in phase · OBV NEUTRAL
Current IV 47.1%
IV Percentile 4th %ile
Put/Call OI Skew 0.23x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact HLF Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
BHST UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV N/A
IV Percentile N/A
Put/Call OI Skew N/A
IV Regime Unclassified
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact BHST Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
HLF Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $1.6B market capitalization and 9.8% operating margin.
OpEx & R&D Reinvestment 67.8% of Rev ($3.58B)
90D Engineering Disclosures 0 Published
BHST Moat Profile Cyclical / Execution-Driven Positioning
Packaged Foods Operator
Competes within the Packaged Foods value chain with $29.9M market capitalization and -18.0% operating margin.
OpEx & R&D Reinvestment 77.0% of Rev ($27M)
90D Engineering Disclosures 0 Published

Investor FAQ HLF vs BHST Key Questions & Quantitative Answers

As of Nov 20, 2026, Herbalife Ltd. (HLF) is the stronger overall head-to-head candidate over BioHarvest Sciences Inc. (BHST) in the Tradestie Institutional Equity Comparison Engine, winning 9–1 core matrix metrics and 5–1 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HLF carries a Unified Composite Score of 47.4/100 (HOLD) at $15.53 (5.1x Forward P/E, 9.8% operating margin), whereas BHST carries 58.2/100 (HOLD) at $1.30 (N/M Forward P/E, -18.0% operating margin). Composite vs. Pillar Nuance: While BHST currently prints a higher short-term Unified Composite Score (58.2/100 HOLD vs. HLF 47.4/100 HOLD), HLF captures the overall institutional head-to-head verdict (9–1 matrix metrics and 5–1 across the 6 pillars) due to superior fundamental profitability (9.8% vs. -18.0% operating margin) and revenue trajectory (+6.0% vs. +3.8% YoY). Technical & Structure Timing Caution: HLF trades in a Markup technical trend (SURGE options phase, RSI 59.0); meanwhile BHST is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.2). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.

HLF leads the Growth & Scale pillar: HLF posts +6.0% YoY revenue growth and +31.5% YoY earnings growth on $5.28B TTM revenue (77.6% gross margin, 9.8% operating margin), compared with BHST at +3.8% YoY revenue growth and +0.0% YoY earnings growth on $35M TTM revenue (59.0% gross margin, -18.0% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HLF cumulative revenue shifted +3.1% while BHST shifted +200.0%. In operating R&D and SG&A reinvestment, HLF deploys 67.8% of Rev ($3.58B) (0 90-day corporate R&D disclosures) versus 77.0% of Rev ($27M) (0 disclosures) for BHST.

HLF screens cheaper on headline valuation multiples. HLF trades at 5.1x Forward P/E, 9.2x Trailing P/E, 0.61x PEG, and 0.6x EV/Revenue (6.4% FCF margin), whereas BHST trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.7x EV/Revenue (-26.6% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HLF (0.0% ROE) versus BHST (-142.5% ROE) capital efficiency.

In options market volatility and institutional positioning, HLF carries 47.1% implied volatility (4th %ile, Compressed (<25th %ile)), a 0.23x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (1.02β · 50% Vol realized risk). By comparison, BHST carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.25β · 86% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.